In the past one week, the stock of the pharmaceutical company has rallied 14 per cent as compared to 0.16 per cent decline in ...

Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...

While supply chain diversification and the US Biosecure Act can help Divi's target the $800 million revenue opportunity from ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

The Nifty Pharma index closed on a positive note on Friday. Shares of Granules India Ltd.(up 4.41 per cent), Ipca ...

A global pharmaceutical firm has acquired a new premises as part of a significant expansion of its operations in a Scottish city.

The most notable contributor to exports was the launch of the Xanomeline Active Pharmaceutical Ingredient (API).

Since then, while advising laboratories globally on energy and water usage, chemical and consumable waste, and sourcing ...

Divi's Laboratories share price rose 12.02% this week, driven by Citi Research's 'buy' rating and a target price of ₹6,400.

Benchmark NSE Nifty50 index was down 68.61 points at 24929.85, while the BSE Sensex was down 252.12 points at 81359.29. Among ...

The Nifty Pharma index has so far this year gained 54.42 percent while the benchmark Nifty advanced 26.94 percent in the same ...

IntroductionPharmacovigilance, a critical component of the pharmaceutical industry, involves the detection, assessment, ...